Securian Asset Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $294K | Hold |
1,310
| – | – | 0.01% | 842 |
|
|
2026
Q1 | $226K | Hold |
1,310
| – | – | 0.01% | 866 |
|
|
2025
Q4 | $261K | Sell |
1,310
-976
| -43% | -$177K | 0.01% | 850 |
|
|
2025
Q3 | $358K | Sell |
2,286
-200
| -8% | -$31.8K | 0.01% | 811 |
|
|
2025
Q2 | $377K | Sell |
2,486
-100
| -4% | -$13.3K | 0.01% | 778 |
|
|
2025
Q1 | $389K | Sell |
2,586
-100
| -4% | -$16.8K | 0.01% | 768 |
|
|
2024
Q4 | $496K | Sell |
2,686
-100
| -4% | -$19.3K | 0.01% | 690 |
|
|
2024
Q3 | $549K | Sell |
2,786
-100
| -3% | -$20.8K | 0.02% | 660 |
|
|
2024
Q2 | $596K | Sell |
2,886
-100
| -3% | -$22.7K | 0.02% | 609 |
|
|
2024
Q1 | $809K | Sell |
2,986
-235
| -7% | -$56.1K | 0.02% | 519 |
|
|
2023
Q4 | $761K | Sell |
3,221
-358
| -10% | -$70.4K | 0.02% | 520 |
|
|
2023
Q3 | $701K | Sell |
3,579
-545
| -13% | -$112K | 0.02% | 530 |
|
|
2023
Q2 | $867K | Hold |
4,124
| – | – | 0.02% | 510 |
|
|
2023
Q1 | $832K | Hold |
4,124
| – | – | 0.02% | 515 |
|
|
2022
Q4 | $899K | Sell |
4,124
-156
| -4% | -$34.1K | 0.03% | 485 |
|
|
2022
Q3 | $842K | Hold |
4,280
| – | – | 0.03% | 485 |
|
|
2022
Q2 | $916K | Hold |
4,280
| – | – | 0.02% | 533 |
|
|
2022
Q1 | $1.22M | Sell |
4,280
-100
| -2% | -$30.8K | 0.02% | 517 |
|
|
2021
Q4 | $1.65M | Hold |
4,380
| – | – | 0.03% | 459 |
|
|
2021
Q3 | $1.81M | Hold |
4,380
| – | – | 0.04% | 408 |
|
|
2021
Q2 | $1.62M | Sell |
4,380
-335
| -7% | -$112K | 0.03% | 444 |
|
|
2021
Q1 | $1.37M | Hold |
4,715
| – | – | 0.03% | 475 |
|
|
2020
Q4 | $1.18M | Sell |
4,715
-110
| -2% | -$26.2K | 0.03% | 498 |
|
|
2020
Q3 | $1.09M | Sell |
4,825
-238
| -5% | -$49.4K | 0.03% | 495 |
|
|
2020
Q2 | $883K | Hold |
5,063
| – | – | 0.02% | 526 |
|
|
2020
Q1 | $639K | Hold |
5,063
| – | – | 0.02% | 564 |
|
|
2019
Q4 | $773K | Sell |
5,063
-415
| -8% | -$57.5K | 0.02% | 634 |
|
|
2019
Q3 | $725K | Sell |
5,478
-377
| -6% | -$50.5K | 0.02% | 654 |
|
|
2019
Q2 | $831K | Hold |
5,855
| – | – | 0.02% | 615 |
|
|
2019
Q1 | $850K | Hold |
5,855
| – | – | 0.02% | 601 |
|
|
2018
Q4 | $663K | Hold |
5,855
| – | – | 0.02% | 643 |
|
|
2018
Q3 | $788K | Sell |
5,855
-100
| -2% | -$12.3K | 0.02% | 642 |
|
|
2018
Q2 | $669K | Buy |
5,955
+122
| +2% | +$13.2K | 0.02% | 688 |
|
|
2018
Q1 | $623K | Hold |
5,833
| – | – | 0.02% | 699 |
|
|
2017
Q4 | $638K | Sell |
5,833
-232
| -4% | -$25.2K | 0.02% | 708 |
|
|
2017
Q3 | $655K | Buy |
6,065
+100
| +2% | +$10.3K | 0.02% | 662 |
|
|
2017
Q2 | $603K | Sell |
5,965
-100
| -2% | -$9.21K | 0.02% | 684 |
|
|
2017
Q1 | $546K | Buy |
6,065
+183
| +3% | +$15.5K | 0.01% | 715 |
|
|
2016
Q4 | $448K | Buy |
5,882
+169
| +3% | +$12.8K | 0.01% | 778 |
|
|
2016
Q3 | $476K | Hold |
5,713
| – | – | 0.01% | 727 |
|
|
2016
Q2 | $471K | Sell |
5,713
-584
| -9% | -$48.1K | 0.01% | 715 |
|
|
2016
Q1 | $478K | Buy |
6,297
+185
| +3% | +$13.7K | 0.01% | 725 |
|
|
2015
Q4 | $491K | Sell |
6,112
-399
| -6% | -$28.8K | 0.01% | 710 |
|
|
2015
Q3 | $414K | Sell |
6,511
-134
| -2% | -$9.62K | 0.01% | 768 |
|
|
2015
Q2 | $467K | Sell |
6,645
-100
| -1% | -$7.4K | 0.01% | 769 |
|
|
2015
Q1 | $535K | Buy |
6,745
+253
| +4% | +$18.7K | 0.02% | 747 |
|
|
2014
Q4 | $413K | Sell |
6,492
-100
| -2% | -$6.27K | 0.01% | 811 |
|
|
2014
Q3 | $394K | Sell |
6,592
-161
| -2% | -$9.21K | 0.01% | 813 |
|
|
2014
Q2 | $361K | Sell |
6,753
-100
| -1% | -$5.49K | 0.01% | 853 |
|
|
2014
Q1 | $414K | Sell |
6,853
-100
| -1% | -$5.83K | 0.02% | 769 |
|
|
2013
Q4 | $369K | Sell |
6,953
-293
| -4% | -$14.7K | 0.01% | 820 |
|
|
2013
Q3 | $335K | Sell |
7,246
-100
| -1% | -$4.59K | 0.01% | 829 |
|
|
2013
Q2 | $301K | Buy |
+7,346
| New | +$315K | 0.01% | 834 |
|
Other funds holding CRL
AI
Securian Asset Management's CRL Position: Q2 2026 in Review
Securian Asset Management held its Charles River Laboratories (CRL) position steady in Q2 2026 at 1,310 shares worth $294K. The position accounts for 0.01% of the portfolio, ranked #842.
Securian Asset Management first reported a position in CRL in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.81M in Q3 2021. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.
- Securian Asset Management held 1,310 shares of Charles River Laboratories worth $294K as of Q2 2026.
- Securian Asset Management left its Charles River Laboratories share count unchanged in Q2 2026.
- Charles River Laboratories made up 0.01% of Securian Asset Management's portfolio in Q2 2026, its #842 holding.
- Securian Asset Management first reported a position in Charles River Laboratories in Q2 2013 and has held it in 53 quarters since.
- Securian Asset Management's Charles River Laboratories position peaked at $1.81M in Q3 2021.
- 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.
Based on Securian Asset Management's 13F filing for Q2 2026, filed 23 Jul 2026.